Clinical trial
haMSter: a Novel Smartphone Communication Tool for People With MS
NCT04555863 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- haMSter: a Novel Smartphone Communication Tool for People With MS
- Lead sponsor
- Medical University of Vienna
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2020
- Completion date
- June 1, 2021
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
m-health, multiple sclerosis